• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Document › Details

Danaher Corporation. (3/31/20). "Press Release: Danaher Completes Acquisition Of The Biopharma Business Of General Electric Life Sciences, Business Will Be Called Cytiva". Washington, DC.

	Organisation	Danaher Corporation (NYSE: DHR)
	Group	Danaher (Group)
	Organisation 2	GE Biopharma
	Today	Cytiva (formerly GE Biopharma business of GE Life Sciences)
	Group	Danaher (Group)
	Product	LIFE SCIENCES
	Product 2	laboratory equipment and instruments
	Index term	General Electric–Danaher: investment, 201902–202003 acquisition $21.4b in cash of biopharma business of GE Life Sciences
	Person	Gugino, Matthew E. (Danaher 201407 VP Investor Relations)

Danaher Corporation (NYSE: DHR) ("Danaher") announced today the completion of its acquisition of the Biopharma business from General Electric Company's (NYSE: GE) Life Sciences division. As part of Danaher, the business will be called Cytiva and will be a standalone operating company within Danaher's Life Sciences segment.


ABOUT DANAHER

Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets. With more than 20 operating companies, Danaher's globally diverse team of approximately 67,000 associates is united by a common culture and operating system, the Danaher Business System, and its Shared Purpose, Helping Realize Life's Potential. For more information, please visit www.danaher.com.


For further information:

Matthew E. Gugino, Vice President, Investor Relations, Danaher Corporation, 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, D.C. 20037, Telephone: (202) 828-0850, Fax: (202) 828-0860; MEDIA CONTACT: George Sard, Sard Verbinnen & Co, Telephone: (212) 687-8080, Email: gsard@sardverb.com

Record changed: 2020-04-01

Advertisement

More documents for Danaher (Group)

• [1] AB Sciex (d/b/a Sciex). (4/1/20). "Press Release: Sciex Debuts Breakthrough Method for Gene Therapies". Framingham, MA....
• [2] Cepheid. (21/3/20). "Press Release: Cepheid Receives Emergency Use Authorization from FDA for Rapid SARS-CoV-2 Test". Sunnyvale, CA....
• [3] AB Sciex (d/b/a Sciex). (3/19/20). "Press Release: Sciex Statement on the Effects of COVID-19"....
• [4] Cepheid. (2/28/20). "Press Release: Cepheid and Sherlock Biosciences Establish Collaboration on New GeneXpert Tests for Infectious Diseases and Oncology Leveraging CRISPR Technology". Sunnyvale, CA & Cambridge, MA....
• [5] Sophia Genetics S.A.. (1/15/20). "Press Release: IDT Partners with Sophia Genetics to Increase Access to Clinical-grade Technologies". Coralville, IA....
• [6] Danaher Corporation. (10/21/19). "Press Release: Danaher Reaches Agreement to Sell Certain Businesses to Sartorius AG as Part of the GE Biopharma Acquisition Regulatory Process". Washington, DC....
• [7] Sartorius AG. (10/21/19). "Press Release: Sartorius Signs Agreement to Acquire Select Danaher Life Science Platform Businesses". Göttingen....
• [8] AB Sciex (d/b/a Sciex). (9/30/19). "Press Release: Sciex and Protein Metrics Join Forces to Meet Biopharmaceutical Customers’ AI and Automation-driven Data Requirements". Framingham, MA....
• [9] Fluidic Analytics Ltd.. (9/23/19). "Press Release: Fluidic Analytics Welcomes Dr Joe Keegan as Chairman"....
• [10] AB Sciex (d/b/a Sciex). (9/23/19). "Press Release: Sciex Medical Devices Set to Address the Challenges faced by Brazil’s Clinical Diagnostics Laboratories". São Paulo....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2020. Made in Germany.